Assertio Holdings (ASRT) Interest Expenses (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Interest Expenses came in at $775000.0 in Q1 2026, up 1.31% year-on-year from $765000.0 in Q1 2025, and little changed quarter-over-quarter from $772000.0 in Q4 2025.
Assertio Holdings (ASRT) Interest Expenses (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Interest Expenses across 8 years of filings, most recently posting $775000.0 for Q1 2026.
- Interest Expenses for Q1 2026 came in at $775000.0, up 1.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 1.25% YoY), and the FY2025 annual result was $3.1 million, up 1.18% from the prior year.
- Interest Expenses came in at $775000.0 for Q1 2026 at Assertio Holdings, roughly flat from $772000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $9.9 million in Q1 2023 to a low of $758000.0 in Q2 2024.
- The 5-year median for Interest Expenses is $769000.0 (2025), against an average of $1.8 million.
- Across the five-year window, Interest Expenses retreated 13.3% in 2022 and jumped 326.21% in 2023, its largest moves.
- Assertio Holdings' Interest Expenses stood at $2.3 million in 2022, then surged by 326.21% to $9.9 million in 2023, then plunged by 92.31% to $763000.0 in 2024, then grew by 1.18% to $772000.0 in 2025, then climbed by 0.39% to $775000.0 in 2026.
- The last three Interest Expenses figures came in at $775000.0 (Q1 2026), $772000.0 (Q4 2025), and $770000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 4.86 Mn |
| 10 | Assertio Holdings | 150.94 Mn | 79.37 Mn | 7.22 Mn | 775,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 775,000.00 |
| Mar 31, 2026 | 775,000.00 |
| Dec 31, 2025 | 772,000.00 |
| Dec 31, 2025 | 772,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Sep 30, 2025 | 770,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 765,000.00 |
| Mar 31, 2025 | 765,000.00 |
| Dec 31, 2024 | 763,000.00 |
| Dec 31, 2024 | 763,000.00 |
| Sep 30, 2024 | 761,000.00 |
| Sep 30, 2024 | 761,000.00 |
| Jun 30, 2024 | 758,000.00 |
| Jun 30, 2024 | 758,000.00 |
| Mar 31, 2023 | 9.92 Mn |
| Mar 31, 2023 | 9.92 Mn |
| Mar 31, 2022 | 2.33 Mn |
| Mar 31, 2022 | 2.33 Mn |